1343565
Adjunct Professor
Shivashankar Hiriyur Nagaraj
This person does not currently hold a position at QUT.
Personal details
Research field
Biochemistry and cell biology, Microbiology, Oncology and carcinogenesis
Field of Research code, Australian and New Zealand Standard Research Classification (ANZSRC), 2020
Qualifications
- PhD (Macquarie University)
Publications
Filter publications:
A complete list of publications is available at: https://www.qut.edu.au/about/our-people/academic-profiles/shiv.nagaraj
Supervision
HDR current supervisions
- Developing an Integrated Pharmacogenomics Platform to Enhance Medication Safety in Chronic Disease Management
PhD, Principal Supervisor
Other supervisors: Dr Paul Leo - Genetic and Environmental Drivers of Comorbid Chronic Disease: Structural Equation Modelling and Causal Analysis
PhD, Principal Supervisor
Other supervisors: Adjunct Associate Professor Rodney Lea - Unravelling predictors of Adverse Drug Reactions to Cancer drugs using Genomic and Environmental data
PhD, Principal Supervisor
Other supervisors: Dr Paul Leo, Adjunct Associate Professor Rodney Lea, Dr Alison Carey, Associate Professor Mark Adams - Unravelling the Genetic Architecture of Chronic Kidney Disease and Co-Morbidities in Tiwi Islanders: Towards Precision Medicine for Indigenous Australians
PhD, Principal Supervisor
Other supervisors: Dr Paul Leo
HDR completed supervisions (Research Doctorates)
- Characterizing the Genetic Architecture of Chronic Kidney Disease in the Australia's First Peoples Using Statistical Methods (2026)
- Pharmacogenomics and Health Equity: Genetic Determinants of Drug Response in Underrepresented Populations (2026)
- Deep learning mediated identification of the origins of cancer of unknown primary (2024)
- Machine Learning Models for Radiogenomics in Cancer (2024)
- Protein-coding potential of non-coding regions in the human genome (2023)
- Epithelial-mesenchymal Plasticity in Circulating Tumour Cells from Patients with Metastatic Cancers and PDX Models (2022)
- Integrated bioinformatics prototype to improve blood type compatibility testing (2022)
- Functional Roles of EMP-Associated Targets in Breast Cancer Models (2021)
- Identification and Functional Characterisation of TGFB - Regulated and Cell Surface Candidates in Pancreatic Cancer (2021)
- EMT & MET: Underpinning the Phenotypic Plasticity and Chemoresistance in Breast Cancer (2020)
HDR completed supervisions (Research Masters)
The supervisions listed above are only a selection.